Reproducibility of the brazilian portuguese version of the european organization for research and treatment of cancer core quality of life questionnaire used in conjunction with its lung cancer-specific module;Reprodutibilidade da versão em português do brasil do european organization for research and treatment of cancer core quality of life questionnaire em conjunto com seu módulo específico para câncer de pulmão

Jornal Brasileiro de Pneumologia

Volumn 36, Issue 5, 2010, Pages 595-602

  Franceschini, Juliana ^a   Jardim, José Roberto ^a   Fernandes, Ana Luisa Godoy ^a   Jamnik, Sérgio ^a   Santoro, Ilka Lopes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Lung neoplasms; Quality of life; Reproducibility of results

Indexed keywords

EID: 78649440113     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132010000500011     Document Type: Article

References (30)

1. Nicklasson M, Bergman B. Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting. Qual Life Res. 2007;16(6):1019-1028.
2. Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2010: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2009.
3. Franceschini J, Santos AA, El Mouallem I, Jamnik S, Uehara C, Fernandes AL, et al. Assessment of the quality of life of patients with lung cancer using the Medical Outcomes Study 36-item Short-Form Health Survey. J Bras Pneumol. 2008;34(6):387-393.
4. Karnofsky DA, Golbey RB, Pool JL. Preliminary studies on the natural history of lung cancer. Radiology. 1957;69(4):477-488.
5. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-655.
6. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-376.
7. Camelier A, Rosa FW, Salim C, Nascimento OA, Cardoso F, Jardim JR. Using the Saint George's Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: validating a new version for use in Brazil. J Bras Pneumol. 2006;32(2):114-122.
8. Almeida OP. Mini mental state examination and the diagnosis of dementia in Brazil [Article in Portuguese]. Arq Neuropsiquiatr. 1998;56(3B):605-612.
9. Uehara C, Santoro I, Ferreira R. Câncer de pulmão: diagnóstico e estadiamento. In: Nery LE, Fernandes AL, Perfeito JA, editors. Pneumologia. Barueri: Manole; 2006. P. 495-509.
10. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111(6):1710-1717.
11. Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes para Testes de Função Pulmonar. J Pneumol. 2002;28(Suppl 3):S1-S82.
12. Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 Scoring Manual. Brussels: EORTC Quality of Life Group; 2001.
13. Young T, De Haes H, Curran D, Fayers P, Brandberg Y, Vanvoorden V, et al. Guidelines for assessing quality of life in EORTC clinical trials. Brussels: EORTC Quality of Life Group; 2002.
14. Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, et al. EORTC QLQ-C30 Reference Values. Brussels: EORTC Quality of Life Group; 2008.
15. Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol. 1998;9(5):549-557.
16. Chie WC, Yang CH, Hsu C, Yang PC. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13. Qual Life Res. 2004;13(1):257-262.
17. Guzelant A, Goksel T, Ozkok S, Tasbakan S, Aysan T, Bottomley A. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30. Eur J Cancer Care (Engl). 2004;13(2):135-144.
18. Kobayashi K, Takeda F, Teramukai S, Gotoh I, Sakai H, Yoneda S, et al. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer. 1998;34(6):810-815.
19. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37(11):1345-1351.
20. Wan C, Zhang C, Tu X, Feng C, Tang W, Luo J, Meng Q. Validation of the simplified Chinese version of the quality of life instrument EORTC QLQ-LC43 for patients with lung cancer. Cancer Invest. 2008;26(5):504-510.
21. Carpes MF, Mayer AF, Simon KM, Jardim JR, Garrod R. The Brazilian Portuguese version of the London Chest Activity of Daily Living scale for use in patients with chronic obstructive pulmonary disease. J Bras Pneumol. 2008;34(3):143-151.
22. Sousa TC, Jardim JR, Jones P. Validação do Questionário do Hospital Saint George na Doença Respiratória (SGRQ) em pacientes portadores de doença pulmonar obstrutiva crônica no Brasil. J Pneumol. 2000;26(3):119-128.
23. Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol. 2008;34(12):1008-1018.
24. Global Initiative for Chronic Obstructive Lung Disease. Pocket guide to COPD diagnoses, management and prevention - A guide for healthcare professionals. Bethesda: National Institutes of Heart, Lung, and Blood Institute; 2009.
25. Nowak AK, Stockler MR, Byrne MJ. Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol. 2004;22(15):3172-3180.
26. Griffin JP, Koch KA, Nelson JE, Cooley ME; American College of Chest Physicians. Palliative care consultation, quality-of-life measurements, and bereavement for end-of-life care in patients with lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):404S-422S.
27. Ozturk A, Sarihan S, Ercan I, Karadag M. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy. Am J Clin Oncol. 2009;32(1):65-72.
28. Sarna L, Evangelista L, Tashkin D, Padilla G, Holmes C, Brecht ML, et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest. 2004;125(2):439-445.
29. Jones PW, Bergman BL. Life quality assessment in obstructive lung disease. Poor correlation between spirometry and patients' evaluation. [Article in Swedish]. Lakartidningen. 1990;87(16):1372-1375.
30. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest. 2004;125(1):27-37.